Erste Group raises AbbVie estimate to USD 16.34 for AbbVie stock

Published on 10/16/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AbbVie stock costs EUR 252.85 on October 16, 2026 at Lang & Schwarz. Third-quarter results are due October 30, 2026 before market open.

Analyst outlook and reporting dates

Erste Group lifted its fiscal 2027 earnings estimate from USD 16.19 to USD 16.34 on October 8, 2026.
AbbVie reported USD 16.99 billion in second-quarter revenue on July 31, 2026, up 10.20 percent year over year.
AbbVie stock trades at EUR 252.85 at 10:01 a.m. CEST at Lang & Schwarz on October 16, 2026.

Extreme Makroaufnahme irisierender pharmazeutischer Kristallstrukturen unter polarisiertem Mikroskoplicht — AbbVie Inc. US00287Y1091 Makrofotografie irisierender kristalliner Molekülstrukturen unter polarisiertem Mikroskoplicht Biopharma Forschung, Illustration mit AI erstellt.

AbbVie Inc. (US00287Y1091) was trading at EUR 252.85 at Lang & Schwarz on October 16, 2026, while Erste Group raised its fiscal 2027 earnings estimate. According to MarketBeat, the estimate increased to USD 16.34 per share from USD 16.19 on October 8, 2026.

What does the estimate change?

The revision adds USD 0.15 per share to Erste Group's fiscal 2027 forecast. MarketBeat also reported that Erste Group maintained a Buy rating, while the current-year consensus stood at USD 13.95 per share on October 14, 2026.

The comparison points to a higher earnings view for the year after 2026, but the next company catalyst remains the third-quarter report. AbbVie guided for adjusted earnings per share of USD 3.84 to USD 3.88 in the third quarter during its second-quarter call.

Three events shape the outlook

On July 31, 2026, AbbVie reported second-quarter revenue of USD 16.99 billion, up 10.20 percent year over year, and adjusted earnings per share of USD 3.65. The figures came from the Yahoo Finance transcript of the earnings call.

On September 3, 2026, AbbVie completed its Apogee Therapeutics acquisition, a transaction that TickerScout valued at USD 10.90 billion. On October 8, 2026, Erste Group lifted its fiscal 2027 estimate to USD 16.34 from USD 16.19, according to MarketBeat.

When are the next milestones?

AbbVie is scheduled to report third-quarter 2026 results on October 30, 2026, before the US market opens, according to Yahoo Finance. A quarterly dividend of USD 1.73 per share is scheduled for payment on November 16, 2026, with the record date on October 15, 2026.

Stock quote for German investors

The euro quotation gives German investors a direct intraday reference before AbbVie's next results. The primary listing is on the NYSE under ticker ABBV, and the company is classified in Healthcare and Drug Manufacturers - General.

AbbVie stock was trading at EUR 252.85 at Lang & Schwarz on October 16, 2026, at 10:01 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of AbbVie stock.